Pakistan has emerged as a significant and rapidly growing market for nicotine pouches, a development that has attracted relatively little attention in Western industry and regulatory discussions but that has substantial implications for how the global nicotine pouch category develops over the coming decade. The market’s growth reflects both the size of Pakistan’s existing tobacco user population and the particular appeal of pouches as a discreet, socially acceptable alternative in a cultural context where open smoking carries significant social stigma in certain settings.
Pakistan has approximately 30 million tobacco users — a large market by any measure. The regulatory environment for nicotine pouches has been relatively permissive compared to the restrictions applied to cigarettes, creating commercial space for brands to establish market positions before comprehensive regulation develops. Several international brands have entered or are in the process of entering the market, alongside domestic producers who have moved quickly to capture demand.
The harm reduction potential in the Pakistani context is significant. A large proportion of Pakistani tobacco users consume cigarettes — products that carry the full combustion-related health burden. If even a fraction of these users switched to pouches, the public health impact could be substantial. The challenge is ensuring that the products available meet quality and safety standards, that age verification prevents youth access, and that the regulatory framework develops in ways that support rather than obstruct the harm reduction opportunity.
The Pakistani market also matters for global supply chains. Domestic manufacturing capacity is developing alongside the market, and Pakistan’s position as a lower-cost manufacturing base could influence the global economics of pouch production in ways that affect price points in other markets.
For the global regulatory conversation, the growth of significant nicotine pouch markets in countries like Pakistan complicates the discussion in useful ways. The European and American framing of the issue — focused heavily on youth use in wealthy markets — does not translate directly to markets where the primary harm reduction opportunity involves existing adult smokers rather than preventing nicotine initiation among young people who might otherwise not use tobacco at all.
